康复新液联合泮托拉唑在消化性溃疡患者中的应用效果分析.docVIP

精品论文 参考文献 康复新液联合泮托拉唑在消化性溃疡患者中的应用效果分析 海南省儋州市第一人民医院儿科 河南 儋州 571700 [摘要]目的：探讨康复新液联合泮托拉唑在消化性溃疡患者中的应用效果。方法：严格按照入选标准抽取75例消化性溃疡患者，随机将患者分组，其中38例患者将接受泮托拉唑治疗，此为对照组；另37例患者则接受康复新液联合泮托拉唑治疗，此为观察组；2组患者均治疗2疗程，于治疗结束后对患者进行复查，统计2组治疗效果以及Hp清除情况；于治疗后1年再次对患者进行复查，观察患者病灶复发情况；结果：观察组治疗无效患者仅1例，总有效率高达97.30%，对照组治疗无效患者为8例，总有效率仅为78.95%，有统计学意义（P＜0.01）；2组Hp阴性患者人数相近，清除率分别为75.68%、76.32%，无统计学意义（P＞0.05，X2=2.681）；治疗1年后病灶复发情况，观察组与对照组分别为4例、11例，复发率观察组（10.81%）＜对照组（28.95%），具有统计学意义（P＜0.01）。 结论：消化性溃疡患者采用康复新液与泮托拉唑联合用药，临床治疗效果更为显著，且患者复发率低，值得临床推广。 关键词：消化性溃疡；康复新液；泮托拉唑；临床疗效 【中图分类号】R815.35【文献标识码】A【文章编号】1001-5213(2016)08-0246-02 [Abstract] Objective: To explore the new rehabilitation treatment combined with pantoprazole application results in peptic ulcer patients. Method: taken in accordance with strict inclusion criteria 75 cases of peptic ulcer patients, patient groups randomly, 38 patients will receive pantoprazole, this was the control group; the other 37 patients receiving rehabilitation treatment combined with new pantoprazole treatment, the observation group; 2 patients were treated for 2 courses, after the end of treatment the patient review, statistics group 2 treatment and Hp removals; 1 year after treatment, patients were reviewed again observed in patients with tumor recurrence ; Results: the therapy of patients only 1 case, the total efficiency of up to 97.30% in the control group therapy patients was 8 cases, the total efficiency of only 78.95%, statistically significant (P lt;0.01); 2 Hp-negative group the number of patients similar clearance rates were 75.68%, 76.32%, no significant difference (Pgt; 0.05, X2 = 2.681); lesion after 1 year of treatment relapse in the observation group and the control group were 4 cases, 11 cases of recurrence the rate of the observation group (10.81%) lt;in the control group (28.95%), with statistical significance (P lt;0.01).Conclusion: The patients with peptic ulcer Kangfuxin combination with pantoprazole, clinical treatment effect is more significant, and the re